Ovarian Cancer
Conditions
Keywords
ex vivo, predictive tests, tumor models
Brief summary
Development of ex vivo models of ovarian cancer, fallopian tubes or peritoneum.
Interventions
GENETICcollection of blood, urine, tumor and ascite samples
collection of blood, urine, tumor and ascite samples during ovarian surgery
Sponsors
Centre Francois Baclesse
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient over 18 years old. * Patient with ovarian cancer, carcinoma of the fallopian tubes, or histologically proven peritoneum. All FIGO stages are accepted for the study. * Patient to be managed by surgery (laparoscopy and / or laparotomy).
Exclusion criteria
* Pregnant woman * Persons deprived of liberty or guardianship (including curatorship) * History of any other clinically active malignancy in the last 5 years prior to inclusion
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rates of exploitable ex vivo tumor, blood and urine samples for performing predictive tests | Collection of blood, urine, tumor and ascite samples at the time of ovarian surgery | Number and quality of tumor, blood and urine samples that can be used to perform predictive tests of the response to treatment |
Countries
France
Outcome results
None listed